Classification and Staging of Ph-negative Myeloproliferative Disorders by Histopathology from Bone Marrow Biopsies

References

• Rozman C., Giralt M., Feliu E., Rubio D., Cortés M.-T. Life expectancy of patients with chronic non-leukemic myeloproliferative disorders. Cancer 1991; 67: 2658–2665
   PubMed Web of Science ®Google Scholar
• Cortelazzo S., Viero P., Finazzi G., D'Emilio A., Rodeghiero F., Barbui T. Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. J. Clin. Oncol. 1990; 8: 556–562
   PubMed Web of Science ®Google Scholar
• Van Genderen P. J., Michiels J. J. Primary thrombocythemia: diagnosis, clinical manifestations and management. Ann. Hematol. 1993; 67: 57–62
   PubMed Web of Science ®Google Scholar
• Pearson T. C., Messinezy M. Polycythemia and thrombocythaemia in the elderly. Baillieres Clin. Hematol. 1987; 1: 355–387
   PubMedGoogle Scholar
• Landaw S. A. Polycythemia vera and other polycythemic states. Clin. Lab. Med. 1990; 10: 857–871
   PubMed Web of Science ®Google Scholar
• Murphy S. Polycythemia vera. Disease-a-month 1992; 38: 153–212
   PubMedGoogle Scholar
• Rain J. D. Clinical and laboratory assessment and therapeutic problems in longstanding polycythemia vera. Nouv. Rev. Fr. Hematol. 1994; 36: 197–203
   PubMedGoogle Scholar
• Barbui T., De Gaetano G., Finazzi G., Landolfi R., Marchioli R., Patrono C., Tognoni G. Clinical epidemiology in 1,213 patients with polycythemia vera. Ann. Int. Med. 1996, in press
   Google Scholar
• Visani G., Finelli C., Castelli V., et al. Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients. Br. J. Haematol. 1990; 75: 4–9
   PubMed Web of Science ®Google Scholar
• Weinstein I. M. Idiopathic myelofibrosis: historical review, diagnosis, and management. Blood Rev. 1991; 5: 98–104
   PubMed Web of Science ®Google Scholar
• Loewy G., Mathew A., Distenfeld A. Skin manifestation of agnogenic myeloid metaplasia. Am. J. Hematol. 1994; 45(2)167–170
   PubMed Web of Science ®Google Scholar
• Kaplan K. R., Mitchell D. G., Steiner R. M., Murphy S., Vinitski S., Rao V. M., Burk D. L., Rifkin M. D. Polycythemia vera and myelofibrosis: correlation of MR imaging, clinical, and laboratory findings. Radiology 1992; 183: 329–334
   PubMed Web of Science ®Google Scholar
• Ellis J. T., Peterson P., Geller ST A., et al. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and secondary hematologic malignancies. Semin. Hematol. 1986; 23: 144–155
   PubMed Web of Science ®Google Scholar
• Lagier R., Baud C. A. Osteomyelosclerosis following polycythaemia vera: radiological correlation in a femur. Eur. J. Radiol. 1990; 10: 15–18
   PubMed Web of Science ®Google Scholar
• Thiele J., Wagner ST, Degel Ch., Dienemann D., Wienhold ST, Zankovich R., Fischer R., Stein H. Megakaryocyte precursors (pro- and megakaryoblasts) in bone marrow tissue from patients with reactive thrombocytosis, polycythemia vera, and primary (essential) thrombocythemia. Virchows Arch. [B] 1990; 58: 295–302
   Google Scholar
• Thiele J., Rompcik V., Wagner ST, Fischer R. Vascular architecture and collagen type IV in primary myelofibrosis and polycythaemia vera: an immunomorphometric study on trephine biopsies of the bone marrow. Br. J. Haematol. 1992; 80: 227–334
   PubMed Web of Science ®Google Scholar
• Dickstein J. I., Vardiman J. W. Hematopathologic findings in myeloproliferative disorders. Semin. Oncol. 1995; 22: 355–373
   PubMed Web of Science ®Google Scholar
• Tefferi A., Silverstein M. N. Agnogenic myeloid metaplasia. Leukemia & Lymphoma 1996
   Web of Science ®Google Scholar
• Castro-Malaspina H. Pathogenesis of myelofibrosis: role of in-effective megakaryopoiesis and megakaryocyte components. Prog. Clin. Biol. Res. 1984; 154: 427–451
   PubMedGoogle Scholar
• Thiele J., Chen Y. S., Kvasnicka H. M., Diehl V., Fischer R. Evolution of fibro-osteosclerotic bone marrow lesions in primary (idiopathic) osteomyelofibrosis—a histomorphometric study on sequential trephine biopsies. Leukemia & Lymphoma 1994; 14: 163–169
   PubMed Web of Science ®Google Scholar
• Yonemitsu H., Okuda K. Essential thrombocythemia terminating in myelofibrosis and myeloblastic transformation. Jpn. J. Med. 1985; 24(1)57–61
   PubMedGoogle Scholar
• Georgii A., Vykoupil K.-F., Buhr T., Choritz H., Döhler U., Kaloutsi V., Werner M. Chronic myeloproliferative disorders in bone marrow biopsies. Path. Res. Pract. 1990; 186: 3–27
   PubMed Web of Science ®Google Scholar
• Hernandez J. M., Orfao A., Gonzalez M., Cuesta B., Lopez-Berges M. C., Canizo M. C., Ciudad J., San Miguel J. F. Immunophaenotypic characterisation of acute leukaemia after polycythaemia vera. J. Clin. Pathol. 1993; 46: 668–671
   PubMed Web of Science ®Google Scholar
• Najfeld V., Coyle T., Berk P. D. Transformation of polycythemia vera to acute nonlymphocytic leukemia accompanied by t(1;3) (p36;q21) karyotype). Cancer Genet. Cytogenet. 1988; 33: 193–200
   PubMed Web of Science ®Google Scholar
• Bartl R., Frisch B., Wilmanns W. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD). Eur. J. Haematol. 1993; 40(1)41–52
   Google Scholar
• Hernandez J. M., San Miguel J. F., Gonzalez M., Orfao A., Canizo M. C., Bascones C., Hernandez J., Lopez Borrasca A. Development of acute leukaemia after idiopathic myelofibrosis. J. Clin. Path. 1992; 45(5)427–430
   PubMed Web of Science ®Google Scholar
• Kurashima K., Kawamura Y., Ohka T., Hayashi M., Matsuda T. Primary myelofibrosis terminating in megakaryoblastic crisis. Jpn. J. Med. 1990; 29(2)226–229
   PubMedGoogle Scholar
• Koza I., Babusikova O. Sequential development of chronic lymphocytic leukemia in a patient with polycythemia vera. Neoplasma 1988; 35: 77–80
   PubMed Web of Science ®Google Scholar
• Roth A. D., Oral A., Przepiorka D., Gollin S. M., Chervenick P. A. Chronic myelogenous leukemia and acute lymphoblastic leukemia occurring in the course of polycythemia vera. Am. J. Hematol. 1993; 43: 123–128
   PubMed Web of Science ®Google Scholar
• Hoffman R., Estren S., Kopel S., et al. Lymphoblastic-like leukemic transformation of polycythemia vera. Ann. Intern. Med. 1978; 89: 71
   PubMed Web of Science ®Google Scholar
• Peterson P., Ellis J. T., Block M. H., et al. The occurrence of non-Hodgkin's lymphoma in polycythemia vera. Lab. Invest. 1985; 52: 51
   Google Scholar
• Schlaifer D., Dastugue N., Brousset P., Delsol G., Muller C., Rigal-Huguet F., Attal M., Laurent G., Pris J. B-cell lymphoma following polycythemia vera: evidence for the involvement of two different clones. Leukemia 1994; 8: 895–896
   PubMed Web of Science ®Google Scholar
• Sedlacek S. M., Curtis J. L., Weintraub J., Levin J. Essential thrombocythemia and leukemic transformation. Medicine 1986; 65(6)353–364
   PubMed Web of Science ®Google Scholar
• Chen Y. H., Mishoulam H., Mir J. A., Choi Y. S., Schade S. G. Blastic transformation in a case of essential thrombocythemia. South. Med. J. 1987; 80(8)1040–1043
   PubMed Web of Science ®Google Scholar
• Emilia G., Sacchi S., Temperani P., Longo R., Vecchi A. Progression of essential thrombocythemia to blastic crisis via idiopathic myelofibrosis. Leukemia and Lymphoma 1993; 9: 423–426
   PubMed Web of Science ®Google Scholar
• Kimura A., Fujimoro T., Inada T., Imamura N., Oguma N., Kajihara H., Mtasiwa D. M., Katoh O., Fujimura K., Kuramoto A. Blastic transformation in essential thrombocythemia. In vitro differentiation of blast cells in granulocytic, erythroid, and megakaryocytic lineages. Cancer 1990; 65(7)1538–1544
   PubMed Web of Science ®Google Scholar
• Vinti H., Taillan B., Pesce A., Michiels J. F., Bayle J., Cassuto J. P. Megakaryoblastic transformation of essential thrombocythemia, hypercalcemia, and lytic bone lesions (letter). Acta Haematol. (Basel) 1990; 83(1)53
   PubMed Web of Science ®Google Scholar
• Honma K., Moto K., Ohnishi Y., Kimura K. Blastic transformation of essential thrombocythemia. A case report. Acta. Pathol. Jpn. 1989; 39(10)670–676
   PubMedGoogle Scholar
• Selleri C., Alfinito F., Del Vecchio L., Luciano L., De Renzo A., Rotoli B. Cytoplasmic GPIIb-IIIa and cytokine secretion by blasts in a case of megakaryoblastic transformation of essential thrombocythemia. Leukemia and Lymphoma 1993; 10: 497–500
   PubMed Web of Science ®Google Scholar
• Shibata K., Shimamoto Y., Suga K., Sano M., Matsuzaki M., Yamaguchi M. Essential thrombocythemia terminating in acute leukemia with minimal myeloid differentiation—a brief review of recent literature. Acta Haematol. (Basel) 1994; 91(2)84–88
   PubMed Web of Science ®Google Scholar
• Van De Pette J. E. W., Prochazka A. V., Pearson T. C., Singh A. K., Dickson E. R., Wetherley-Mein G. Primary thrombocythemia treated with busulfan. Br. J. Haematol. 1986; 62: 229–237
   PubMed Web of Science ®Google Scholar
• Cortelazzo S., Viero P., Finazzi G., D'Emilio A., Rodeghiero F., Barbui T. Hydroxyurea in the treatment of patients with essential thrombocythemia to high risk of thrombosis: a prospective randomized trial. N. Engl. J. Med. 1995; 17: 1132–1136
   Web of Science ®Google Scholar
• Lengfelder E., Hochhaus A., Hehlmann R. Therapy of 143 essential thrombocythemia patients by interferon alpha versus hydroxyurea. 1995, (submitted)
   Google Scholar
• Parmentier C., Cardet P. The use of 32 phosphorus (32P) in the treatment of polycythemia vera. Nouv. Rev. Fr. Hematol. 1994; 36: 189–192
   PubMedGoogle Scholar
• Messora C., Bensi L., Vecchi A., Longo R., Giacobbi F., Temperani P., Bevini M., Emilia G., Sacchi S. Cytogenetic conversion in a case of polycythaemia vera treated with interferon-alpha. Br. J. Haematol. 1994; 86: 402–404
   PubMed Web of Science ®Google Scholar
• Peterson P., Murphy S., Iland H. J., Geller S. A., Ellis J. T. Occurrence of acute leukemia in treated essential thrombocythemia. Lab. Invest. 1994; 70: 118
   Web of Science ®Google Scholar
• Berk P. D., Goldberg J. D., Silverstein M. N., Weinfeld A., Donovan P. B., Ellis J. T., Landaw S. A., Laszlo J., Najean Y., Psciotta A. V., Wasserman L. R. Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. N. Engl. J. Med. 1981; 34: 441–447
   Web of Science ®Google Scholar
• Hawkins T. E., Carter J. M., Romeril K. R., Jackson S. R., Green G. J. Lymphoma transformation in polycythaemia vera treated with hydroxyurea (letter). Am. J. Hematol. 1993; 44: 290
   PubMed Web of Science ®Google Scholar
• Weinfeld A., Swolin B., Westin J. Acute leukaemia after hydroxyurea therapy in polycythaemia vera and allied disorders: prospective study of efficency and leukaemogenicity with therapeutic implications. Eur. J. Haematol. 1994; 52: 134–139
   PubMed Web of Science ®Google Scholar
• Brandt L., Anderson H. Survival and risk of leukaemia in polycythaemia vera and essential thrombocythaemia treated with oral radiophosphorus: are safer drugs available. Eur. J. Haematol. 1995; 54(1)21–26
   PubMedGoogle Scholar
• Silverstein M. N., Petitt R. M., Fleming L. A., St Knight J. R. C., Schacter L. P. Anagrelide: a new drug for treating thrombocytosis. N. Engl. J. Med. 1988; 318: 1292–1294
   PubMed Web of Science ®Google Scholar
• Anagrelide Study Group. Anagrelide—a therapy for thrombo-cythemic states: experience in 577 patients. Am. J. Med. 1992; 92: 69–76
   PubMed Web of Science ®Google Scholar
• Landolfi R., Ciabattoni G., Patrigriani P., Castellana M. A. L., Pogliani E., Bizzi B., Patrono C. Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo. Blood 1992; 80: 1965–1971
   PubMed Web of Science ®Google Scholar
• De Mascarel A. Contribution of bone marrow biopsy in the diagnosis and prognosis of polycythemia vera. Nouv. Rev. Fr. Hematol. 1994; 36: 165–166
   PubMedGoogle Scholar
• Werner M., Kaloutsi V., Kausche F., Buhr T., Georgii A. Evidence from moleculargenetic and cytogenetic analyses that bone marrow histopathology gives reliable diagnoses in chronic myeloproliferative disorders. Virchows Arch. [B] 1993; 63: 199–204
   Google Scholar
• Werner M., Nolte M., Kaloutsi V., Buhr Th., Kausche F., Georgii A. Karyotype findings and molecular analysis of the bcr gene rearrangement supplementing the histological classification of chronic myeloproliferative disorders. Lab. Invest. 1995; 72: 405–410
   PubMed Web of Science ®Google Scholar
• Nolte M., Werner M., Ewig M., von Wasielewski R., Wilkens L., Georgii A. Demonstration of the Philadelphia translocation by fluorescence in situ hybridization (FISH) in paraffin sections and identification of aberrant cells by a combined FISH/immunophenotyping approach. Histopathology 1995; 26: 433–437
   PubMed Web of Science ®Google Scholar
• Bernhards J., Weitzel B., Werner M., Rimpler M., Georgii A. A new histological embedding method by low-temperature polymerisation of methyl methacrylate allowing immuno- and enzyme histochemical studies on semi-thin sections of undecalcified bone marrow biopsies. Histochemistry 1992; 98: 145–154
   PubMedGoogle Scholar
• Georgii A., Bernhards J., Werner M. Die neue Hannover-Methode zur Kunststoff-Einbettung vom Knochenmark: Kalt-Polymerisation von Methyl-Methacrylat. Pathologe 1995; 16: 28–33
   PubMed Web of Science ®Google Scholar
• Nafe R., Georgii A., Kaloutsi V., Fritsch R. S., Choritz H. Planimetric analysis of megakaryocytes and the four main groups of chronic myeloproliferative disorders. Virchows Arch. [B] 1991; 61: 111–116
   Google Scholar
• Nafe R., Kaloutsi V., Choritz H., Georgii A. Elliptic fourier analysis of megakaryocyte nuclei in chronic myeloproliferative disorders. Anal. Quant. Cytol. Histol. 1992; 14: 391–397
   PubMed Web of Science ®Google Scholar
• Nafe R., Kaloutsi V., Fritsch R. S., Georgii A. Quantitative cytomorphology of megakaryocytes in chronic myeloproliferative disorders-Analysis of planimetric and numeric characteristics by means of a knowledge based system. Exp. Pathol. 1991; 40: 213–219
   Google Scholar
• Peterson P., Ellis J. T., Geller S. A., et al. Increased incidence of acute leukemia in spent polycythemia following myelo-suppressive therapy. Lab. Invest. 1986; 54: 48
   Google Scholar
• Najean Y., Dresch C., Rain J. D. The very-long-term course of polycythemia: a complement to the previously published data of the Polycythaemia Vera Study Group. Br. J. Haematol. 1994; 86: 233–235
   PubMed Web of Science ®Google Scholar
• Anger B., Haug U., Seidler R., Heimpel H. Polycythemia vera. A. clinical study of 141 patients. Blut 1989; 59: 493–500
   PubMedGoogle Scholar
• Swolin B., Weinfeld A., Westin J. A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course. Blood 1988; 72: 386–395
   PubMed Web of Science ®Google Scholar
• Hino K., Sato S., Sakashita A., Tomoyasu S., Tsuruoka N., Koike T. Megakaryoblastic transformation associated with disseminated intravascular coagulation in the course of polycythemia vera: a case report. Rinsho Ketsueki (Jpn. J. Clin. Hematol.) 1992; 33: 500–506
   PubMedGoogle Scholar
• Wong K. F., Chan J. K., Ma S. K., Chu Y. C. Megakaryoblastic transformation of polycythemia vera associated with hypercalcemia. Am. J. Hematol. 1993; 43: 240–242
   PubMed Web of Science ®Google Scholar
• Barosi G., Ambrosetti A., Burratti A., et al. Splenectomy for patients with myelofibrosis with myeloid metaplasia; pretreatment variables and outcome prediction. Leukemia 1993; 7: 200–206
   PubMed Web of Science ®Google Scholar
• Georgii A., Vykoupil K. F., Thiele J. Chronic megakaryocytic granulocytic myelosis -CMGM -. A subtype of chronic myeloid leukemia. Virchows Arch. A Path Anat and Histol 1980; 389: 253–268
   PubMed Web of Science ®Google Scholar
• Buhr Th., Georgii A., Choritz H. Myelofibrosis in chronic myeloproliferative disorders: Incidence among subtypes according to the Hannover classification. Path. Res. Pract. 1993; 189: 121–132
   PubMed Web of Science ®Google Scholar
• Buhr T., Choritz H., Georgii A. The impact of megakaryocyte proliferation for the evolution of myelofibrosis. Histological follow-up study in 186 patients with chronic myeloid leukaemia. Virchows Arch. [A] 1992; 420: 473–478
   Web of Science ®Google Scholar
• Lewis S. M., Szur L. Malignant myelosclerosis. Br. Med. J. 1963; 2: 472–477
   PubMedGoogle Scholar
• Amberger D. M., Saleem A., Kemp B. L., Truong L. D. Acute myelofibrosis—a leukemia of pluripotent stem cell. A report of three cases and review of the literature. Ann. Clin. Lab. Sci. 1990; 20(6)409–414
   PubMed Web of Science ®Google Scholar
• Becher R. Acute myelofibrosis in megakaryoblastic leukemia with translocation between chromosomes 8 and 14. Klin. Wschr. 1988; 66(12)556
   PubMedGoogle Scholar
• Bullorsky E. O., Shanley C. M., Stemmelin G., Venditti J., Lajous J. R. Acute megakaryoblastic leukemia with massive myelofibrosis: complete remission and reversal of marrow fibrosis with allogeneic bone marrow transplantation as the only treatment. Bone Marrow Transplantation 1990; 6(6)449–452
   PubMed Web of Science ®Google Scholar
• Marino G. G. Acute myelofibrosis: report of a case and review of current literature. J. Am. Osteopath. Assoc. 1989; 89(10)1323–1326
   PubMedGoogle Scholar
• Thiele J., Krech R., Vykoupil K. F., Georgii A. Malignant (acute) myelosclerosis—a clinical pathological study in 6 patients. Scand. J. Haematol. 1984; 33: 95–105
   PubMedGoogle Scholar
• Hruban R. H., Kukajda F. P., Mann R. B. Acute myelofibrosis. Immunohistochemical study of four cases and comparison with acute megakaryocytic leukemia. Am. J. Clin. Pathol. 1987; 88: 578–588
   PubMed Web of Science ®Google Scholar